Chieki Wada
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 3
-
- Genetic factors in colorectal cancer 8
- Oncology top 10%
- Lung Cancer Research Studies 3
- Immunology and Allergy top 10%
- Rheumatology top 10%
-
- Chronic Lymphocytic Leukemia Research 3
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Neuroendocrine Tumor Research Advances 3
-
- Bladder and Urothelial Cancer Treatments 3
-
- Mitochondrial Function and Pathology 2
- Co-authors
- H OhtaniTohru AkahoshiShigeru HosakaΤοyoaki UchidaKen KoshibaHirohito M. KondoShinichi EgawaToru Kameya
- Journals
- The Journal of Urology (3 papers)International Journal of Cancer (2 papers)Blood (2 papers)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Chieki Wada
32 papers receiving 897 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 208
- Pathology and Forensic Medicine 232
- Oncology 319
- Immunology and Allergy 69
- Rheumatology 138
Countries citing papers authored by Chieki Wada
This map shows the geographic impact of Chieki Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chieki Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chieki Wada more than expected).
Fields of papers citing papers by Chieki Wada
This network shows the impact of papers produced by Chieki Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chieki Wada. The network helps show where Chieki Wada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chieki Wada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 31 | |
| 2 | 1998 | 4 | |
| 3 | 1996 | 26 | |
| 4 | [Nucleotide sequences at intron 6 and exon 7 junction of fibroblast growth factor receptor 2 and rapid mutational analysis in Apert syndrome]. | 1996 | 5 |
| 5 | 1995 | 16 | |
| 6 | 1995 | 29 | |
| 7 | 1995 | 5 | |
| 8 | 1995 | 1 | |
| 9 | 1994 | 7 | |
| 10 | 1993 | 32 | |
| 11 | 1992 | 4 | |
| 12 | A general transcription initiation factor, human transcription factor IID, overexpressed in human lung and breast carcinoma and rapidly induced with serum stimulation. | 1992 | 28 |
| 13 | 1991 | 25 | |
| 14 | 1991 | 7 | |
| 15 | 1990 | 4 | |
| 16 | 1989 | 28 | |
| 17 | 1988 | 1 | |
| 18 | 1988 | 20 | |
| 19 | α-Calcitonin Gene-Related Peptide (α-CGRP) and Alternative RNA Processing Events in Calcitonin/α-CGRP Gene Expression of Human and Rat Lung | 1987 | 4 |
| 20 | 1986 | 25 |
About Chieki Wada
Chieki Wada is a scholar working on Pathology and Forensic Medicine, Genetics, Immunology and Allergy, Cancer Research and Oncology, having authored 33 papers that have together received 922 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (8 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer Genomics and Diagnostics (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Lung Cancer Research Studies (3 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Cancer Research (208 citations), Pathology and Forensic Medicine (232 citations), Oncology (319 citations), Immunology and Allergy (69 citations) and Rheumatology (138 citations). Chieki Wada has collaborated with scholars based in Japan, United States and France. Frequent co-authors include H Ohtani, Tohru Akahoshi, Shigeru Hosaka, Τοyoaki Uchida, Ken Koshiba, Hirohito M. Kondo, Shinichi Egawa, Toru Kameya, Handong Wang and Shin Egawa. Their work appears in journals such as The Journal of Urology, International Journal of Cancer, Blood, Gene and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.